Trastuzumab-based treatment of HER2-positive breast cancer: an antibody-dependent cellular cytotoxicity mechanism?

Autor: Arnould, L.1,2 larnould@dijon.fnclcc.fr, Gelly, M.1, Penault-Llorca, F.3, Benoit, L.4, Bonnetain, F.5, Migeon, C.6, Cabaret, V.7, Fermeaux, V.8, Bertheau, P.9, Garnier, J.10, Jeannin, J.-F.2, Coudert, B.11
Zdroj: British Journal of Cancer. 1/30/2006, Vol. 94 Issue 2, p259-267. 9p. 4 Diagrams, 4 Charts.
Databáze: Academic Search Ultimate